Tenet Healthcare Secures $1.9 Billion Revolving Credit Facility and Extends $200 Million Letter of Credit Agreement
Tenet Healthcare Corporation has entered into a new Credit Agreement providing for a senior secured revolving credit facility of up to $1.9 billion, with a $200 million sub-facility for letters of credit. The agreement, effective November 4, 2025, involves JPMorgan Chase Bank, N.A. as administrative agent and includes borrowing availability based on eligible accounts receivable, inventory, and Medicaid supplemental payments. Additionally, Tenet amended its existing Letter of Credit Facility Agreement with Barclays Bank PLC, extending the scheduled maturity date from March 16, 2027, to November 4, 2030, while maintaining an aggregate principal amount of up to $200 million for the issuance of standby and documentary letters of credit.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenet Healthcare Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-266885), on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.